Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1 Classical hematology 1 CNS 1

Conditions

Lymphoma 1 Leukemia 1

Interventions

Cytarabine 905 Cyclophosphamide 899 fludarabine 525 venetoclax 489 fludarabine phosphate 468 Azacitidine 460 Rituximab 431 Methotrexate 419 Etoposide 320 Filgrastim 299 Busulfan 296 Dexamethasone 286 Vincristine 285 Daunorubicin 283 Peripheral Blood Stem Cell Transplantation 258 Whole-Body Irradiation 243 Mycophenolic Acid 232 Decitabine 230 Granulocyte Colony-Stimulating Factor 227 Tacrolimus 220 Imatinib Mesylate 211 Idarubicin 205 Melphalan 202 Cyclosporine 182 Doxorubicin 177 Radiotherapy 169 Prednisone 163 Dasatinib 163 Mitoxantrone 161 Lenalidomide 160

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Clozapine × Other hematologic neoplasm × Clear all

NCT04074213 2019-08-30

CLOZARIX

University Hospital, Caen

1,000,000 enrolled

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡